Dual-listed AFT Pharmaceuticals has raised $73.8 million after a capital raise and share sell-down on Wednesday.
It announced to the NZX yesterday a $10m capital raise through new share issuance, as well as a sell-down of $63.8m in shares, from both the company’s founder and managing
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
